$PMCB Dr. Manuel Hidalgo, a member of PharmaCyte’s Medical and Scientific Advisory Board and the Principal Investigator in PharmaCyte’s planned clinical trial in pancreatic #cancer, recently spoke in a panel discussion on biological breakthroughs in pancreatic cancer hosted by OncLive.PMCB
In his role at the prestigious Beth Israel Deaconess Medical Center, Dr. Hidalgo oversees all BIDMC’s clinical cancer programs. His groundbreaking work in experimental cancer therapy and tumor model development has led to key advances in the treatment of pancreatic cancer.
Market Data 
Markets 
AI
